GSTM1 and anemia (phenotype): Further research is needed to determine (a) why there was no evidence of a reduced prevalence of anaemia at 36 gw with iron supplementation in this population and (b) if higher Hb or iron status later in pregnancy is beneficial with regard to health outcomes of the mother or infant.